Skip to main content
Equibles

Aaron Ondrey

CFO

Rocket Pharmaceuticals, Inc. (RCKT)

Equibles does not estimate personal net worth.

Get an email with a short summary when Rocket Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get RCKT alerts

About Aaron Ondrey

Aaron Ondrey is recorded as CFO at Rocket Pharmaceuticals, Inc. (RCKT) since March 25, 2024. Rocket Pharmaceuticals, Inc. reported in an 8-K filed August 25, 2025 that Aaron Ondrey resigned as Chief Financial Officer, effective September 5, 2025. Rocket Pharmaceuticals, Inc. reported in an 8-K filed March 29, 2024 that Aaron Ondrey was appointed Chief Financial Officer and Principal Financial Officer, effective March 25, 2024. The proxy statement of Rocket Pharmaceuticals, Inc. reports total compensation of $2,989,763 for Aaron Ondrey in fiscal 2024, including a base salary of $362,662. Rocket Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rocket Pharmaceuticals, Inc. includes Gaurav Shah (CEO and Board Member), Carlos Garcia-Parada (CFO), John Militello (CFO) and 7 others.

“On August 20, 2025, Aaron Ondrey resigned as Chief Financial Officer of Rocket Pharmaceuticals, Inc. (the "Company"), effective September 5, 2025, to pursue other opportunities.”
Rocket Pharmaceuticals, Inc. Form 8-K, filed August 25, 2025 · Read the filing
“On March 25, 2024, Aaron Ondrey was appointed by Rocket Pharmaceuticals, Inc. (the "Company") as the Company's Chief Financial Officer and Principal Financial Officer.”
Rocket Pharmaceuticals, Inc. Form 8-K, filed March 29, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Rocket Pharmaceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Rocket Pharmaceuticals, Inc. (RCKT) $362,662 $2,989,763

Recent activity